Terbium 161- PSMA I&T for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Mar 2026: Trial registered, NCT07441837

The trials

NCT07441837: Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients

State
Not started
Phase
Phase 2
People
60 planned
Started
1 Jul 2026
Primary completion
1 Aug 2028
Arms
Tb-161 PSMA treatment arm
Results
None posted
  1. 2 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.